Related Experiment Videos
[A comparative trial between pilocarpine drops and ocusert-pilocarpine]
Klinische Monatsblatter Fur Augenheilkunde
|July 1, 1976
Summary
Ocusert P 20/P 40 showed mixed results in glaucoma patients. While 27 experienced good outcomes, 26 discontinued treatment due to poor compatibility or lack of effectiveness.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Glaucoma is a progressive optic neuropathy.
- Effective long-term management is crucial for preserving vision.
Purpose of the Study:
- To evaluate the efficacy and tolerability of Ocusert P 20/P 40 in glaucoma patients.
- To assess the suitability of this drug delivery system for glaucoma management.
Main Methods:
- A 5-week clinical trial involving 53 outpatients with glaucoma.
- Administration of Ocusert P 20/P 40 for drug delivery.
- Monitoring for treatment effectiveness and patient compatibility.
Main Results:
- Good therapeutic results and compatibility were observed in 27 out of 53 patients.
- Treatment discontinuation was necessary for 26 patients.
- Reasons for discontinuation included poor tolerability (16 patients) and insufficient efficacy (10 patients).
Conclusions:
- Ocusert P 20/P 40 demonstrates potential but has significant tolerability and efficacy limitations.
- Further research is needed to optimize this glaucoma treatment approach.
- Patient-specific factors may influence the success of Ocusert P 20/P 40 therapy.